StockData
Natural Alternatives International Inc logo

Natural Alternatives International Inc (NAII) stock

NAIINasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.88−0.02 (-2.67%)

Close on Nov 20, 2026Market cap $19.37MP/E –Yield –

Natural Alternatives International revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Natural Alternatives International's revenue for the twelve months ending Jun 30, 2026 was $142.52M, up 9.7% year over year. For fiscal 2026 it was $142.52M, up 9.7% from the year before. Over ten years it grew 2.2% a year on average. The highest annual figure on record is $178.52M in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2026Jun 30, 2026$142.52M+9.7%
FY2025Jun 30, 2025$129.86M+14.1%
FY2024Jun 30, 2024$113.80M-26.1%
FY2023Jun 30, 2023$154.02M-9.9%
FY2022Jun 30, 2022$170.97M-4.2%
FY2021Jun 30, 2021$178.52M+50.2%
FY2020Jun 30, 2020$118.88M-14.0%
FY2019Jun 30, 2019$138.29M+4.4%
FY2018Jun 30, 2018$132.44M+8.6%
FY2017Jun 30, 2017$121.95M+6.8%
FY2016Jun 30, 2016$114.20M+43.6%
FY2015Jun 30, 2015$79.51M+7.5%
FY2014Jun 30, 2014$73.94M+17.7%
FY2013Jun 30, 2013$62.80M-13.8%
FY2012Jun 30, 2012$72.82M+30.3%
FY2011Jun 30, 2011$55.88M–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$34.51M+1.9%
Q3 FY2026CQ1 2026Mar 31, 2026$35.48M+23.3%
Q2 FY2026CQ4 2025Dec 31, 2025$34.80M+2.1%
Q1 FY2026CQ3 2025Sep 30, 2025$37.73M+13.8%
Q4 FY2025CQ2 2025Jun 30, 2025$33.87M+14.8%
Q3 FY2025CQ1 2025Mar 31, 2025$28.77M+14.4%
Q2 FY2025CQ4 2024Dec 31, 2024$34.08M+35.2%
Q1 FY2025CQ3 2024Sep 30, 2024$33.15M-2.4%
Q4 FY2024CQ2 2024Jun 30, 2024$29.49M-17.8%
Q3 FY2024CQ1 2024Mar 31, 2024$25.14M-23.1%
Q2 FY2024CQ4 2023Dec 31, 2023$25.20M-40.4%
Q1 FY2024CQ3 2023Sep 30, 2023$33.97M-21.2%
Q4 FY2023CQ2 2023Jun 30, 2023$35.89M-31.7%
Q3 FY2023CQ1 2023Mar 31, 2023$32.70M-22.8%
Q2 FY2023CQ4 2022Dec 31, 2022$42.30M+12.1%
Q1 FY2023CQ3 2022Sep 30, 2022$43.13M+12.5%
Q4 FY2022CQ2 2022Jun 30, 2022$52.53M+18.3%
Q3 FY2022CQ1 2022Mar 31, 2022$42.37M-8.5%
Q2 FY2022CQ4 2021Dec 31, 2021$37.73M-21.5%
Q1 FY2022CQ3 2021Sep 30, 2021$38.34M-3.5%
Q4 FY2021CQ2 2021Jun 30, 2021$44.39M+26.5%
Q3 FY2021CQ1 2021Mar 31, 2021$46.32M+81.8%
Q2 FY2021CQ4 2020Dec 31, 2020$48.08M+65.2%
Q1 FY2021CQ3 2020Sep 30, 2020$39.73M+36.1%
Q4 FY2020CQ2 2020Jun 30, 2020$35.10M+16.0%
Q3 FY2020CQ1 2020Mar 31, 2020$25.48M-28.1%
Q2 FY2020CQ4 2019Dec 31, 2019$29.10M-19.3%
Q1 FY2020CQ3 2019Sep 30, 2019$29.20M-20.1%
Q4 FY2019CQ2 2019Jun 30, 2019$30.26M-22.8%
Q3 FY2019CQ1 2019Mar 31, 2019$35.46M+11.4%
Q2 FY2019CQ4 2018Dec 31, 2018$36.04M+8.1%
Q1 FY2019CQ3 2018Sep 30, 2018$36.53M+30.1%
Q4 FY2018CQ2 2018Jun 30, 2018$39.21M+21.8%
Q3 FY2018CQ1 2018Mar 31, 2018$31.82M+26.6%
Q2 FY2018CQ4 2017Dec 31, 2017$33.34M+9.1%
Q1 FY2018CQ3 2017Sep 30, 2017$28.07M-17.6%
Q4 FY2017CQ2 2017Jun 30, 2017$32.19M–
Q3 FY2017CQ1 2017Mar 31, 2017$25.14M–
Q2 FY2017CQ4 2016Dec 31, 2016$30.56M–
Q1 FY2017CQ3 2016Sep 30, 2016$34.07M–

More Natural Alternatives International figures

See a number that looks wrong?